California-based DNA testing company 23andMe has filed for Chapter 11 bankruptcy, aiming to restructure its operations and potentially sell its assets after years of financial struggles.
With nearly two decades in the business, the company has processed over 15 million saliva-based testing kits, offering insights into customers’ family origins and certain genetic predispositions.
Genetic information is among the most sensitive personal data a company can handle, often revealing details not jus
